Eosinophilic vasculitis in connective tissue disease
- 31 August 1996
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 35 (2) , 173-182
- https://doi.org/10.1016/s0190-9622(96)90318-7
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Strategies of Anti‐Cytokine Monoclonal Antibody Development: Immunoassay of IL‐10 and IL‐5 in Clinical SamplesImmunological Reviews, 1992
- Shape changes, exocytosis, and cytosolic free calcium changes in stimulated human eosinophils.Journal of Clinical Investigation, 1991
- Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3.Journal of Clinical Investigation, 1988
- Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts.The Journal of Experimental Medicine, 1987
- Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.Journal of Clinical Investigation, 1986
- Massive eosinophilia in rheumatoid arthritis: Report of four casesClinical Rheumatology, 1986
- Two types of inflammatory vascular disease in Sjögren's syndrome. Differential association with seroreactivity to rheumatoid factor and antibodies to Ro (SS‐A) and with hypocomplementemiaArthritis & Rheumatism, 1985
- Studies on C3ahu Binding to Human Eosinophils: Characterization of BindingInternational Archives of Allergy and Immunology, 1984
- Cutaneous clinicopathologic correlation of allergic granulomatosisJournal of the American Academy of Dermatology, 1981
- Rheumatoid Arthritis, Immune Complex Disease, and Hypereosinophilic SyndromeActa Medica Scandinavica, 1979